FR2304336A1 - Composes a effet anti-depressif et procedes de preparation - Google Patents

Composes a effet anti-depressif et procedes de preparation

Info

Publication number
FR2304336A1
FR2304336A1 FR7608019A FR7608019A FR2304336A1 FR 2304336 A1 FR2304336 A1 FR 2304336A1 FR 7608019 A FR7608019 A FR 7608019A FR 7608019 A FR7608019 A FR 7608019A FR 2304336 A1 FR2304336 A1 FR 2304336A1
Authority
FR
France
Prior art keywords
compounds
preparation
methods
depressive effect
depressive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7608019A
Other languages
English (en)
Other versions
FR2304336B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Philips Gloeilampenfabrieken NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Gloeilampenfabrieken NV filed Critical Philips Gloeilampenfabrieken NV
Publication of FR2304336A1 publication Critical patent/FR2304336A1/fr
Application granted granted Critical
Publication of FR2304336B1 publication Critical patent/FR2304336B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7608019A 1975-03-20 1976-03-19 Composes a effet anti-depressif et procedes de preparation Granted FR2304336A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Publications (2)

Publication Number Publication Date
FR2304336A1 true FR2304336A1 (fr) 1976-10-15
FR2304336B1 FR2304336B1 (fr) 1979-09-28

Family

ID=19823424

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7608019A Granted FR2304336A1 (fr) 1975-03-20 1976-03-19 Composes a effet anti-depressif et procedes de preparation

Country Status (27)

Country Link
US (1) US4085225A (fr)
JP (1) JPS6026776B2 (fr)
AR (2) AR211011A1 (fr)
AT (1) AT340895B (fr)
AU (1) AU505358B2 (fr)
BE (1) BE839744A (fr)
CA (1) CA1076142A (fr)
CH (4) CH626057A5 (fr)
DD (1) DD128332A5 (fr)
DE (1) DE2610886A1 (fr)
DK (1) DK144942C (fr)
ES (1) ES446192A1 (fr)
FI (1) FI61875C (fr)
FR (1) FR2304336A1 (fr)
GB (1) GB1535226A (fr)
GR (1) GR60052B (fr)
HU (1) HU171030B (fr)
IE (1) IE43768B1 (fr)
IL (1) IL49238A (fr)
IT (1) IT1063064B (fr)
MX (1) MX9203723A (fr)
NL (1) NL7503310A (fr)
PL (3) PL100052B1 (fr)
SE (1) SE410312B (fr)
SU (3) SU635867A3 (fr)
YU (1) YU39345B (fr)
ZA (1) ZA761434B (fr)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
ATE192042T1 (de) * 1995-08-16 2000-05-15 Lilly Co Eli Potenzierung von serotonin-wirkstoffresponz
IN182588B (fr) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
IN186677B (fr) 1999-11-12 2001-10-20 Sun Pharmaceutical Ind Ltd
US20080021085A1 (en) * 2000-04-13 2008-01-24 Mayo Foundation For Medical Education And Research Method of reducing abeta42 and treating diseases
JP2003530437A (ja) * 2000-04-13 2003-10-14 マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ Ａβ４２低下物質
US7256191B2 (en) * 2000-04-24 2007-08-14 Aryx Therapeutics Materials and methods for the treatment of depression
WO2001080845A2 (fr) * 2000-04-24 2001-11-01 Aryx Therapeutics Substances et méthodes de traitement de la dépression
AU2002342045C1 (en) * 2001-10-12 2009-07-30 Azevan Pharmaceuticals, Inc. Beta-lactamyl vasopressin Vla antagonists
EP2266590A3 (fr) 2002-02-22 2011-04-20 Shire LLC Système d'administration de substances actives et méthodes de protection et d'administration de substances actives
WO2004071431A2 (fr) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Composition et methode de traitement de troubles neurodegeneratifs
CA2532207A1 (fr) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Procedes pharmaceutiques, posologies et formes posologiques pour le traitement de la maladie d'alzheimer
CA2537402C (fr) 2003-09-12 2009-05-05 Pfizer Inc. Associations comprenant des ligands alpha-2-delta et des inhibiteurs du recaptage de la serotonine et de la noradrenaline
DK1689721T3 (da) * 2003-11-26 2010-09-20 Pfizer Prod Inc Aminopyrazolderivater som GSK-3-ihibitorer
WO2005060968A1 (fr) 2003-12-11 2005-07-07 Sepracor Inc. Combinaison d'un sedatif et d'un modulateur des neurotransmetteurs, et methodes permettant d'ameliorer la qualite du sommeil et de traiter la depression
WO2006001877A2 (fr) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Composition pharmaceutique et methode de traitement de troubles neurodegeneratifs
WO2005102366A2 (fr) * 2004-04-19 2005-11-03 Philip Maxwell Satow Combinaisons de lithium et utilisations associees
WO2005108683A1 (fr) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Placages pour parois, murs de soutenement et analogues
WO2006020850A2 (fr) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Composition pharmaceutique et technique de traitement de troubles neurodegeneratifs
WO2006020853A2 (fr) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Composition pharmaceutique et methode de traitement de troubles neurodegeneratifs
WO2006020852A2 (fr) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Composition pharmaceutique et technique de traitement de troubles neurodegeneratifs
JP2008534504A (ja) 2005-03-22 2008-08-28 アゼヴァン ファーマスーティカルズ，インコーポレイテッド 月経前障害を治療するためのβラクタミルアルカン酸
JP2008538577A (ja) * 2005-04-22 2008-10-30 ワイス ジヒドロベンゾフラン誘導体およびその使用
CN101175740A (zh) 2005-04-22 2008-05-07 惠氏公司 二氢苯并呋喃衍生物和其用途
CN101203218A (zh) * 2005-04-22 2008-06-18 惠氏公司 苯并呋喃基链烷胺衍生物和其作为5－ht2c激动剂的用途
JP2008538581A (ja) * 2005-04-22 2008-10-30 ワイス ｛［（２ｒ）−７−（２，６−ジクロロフェニル）−５−フルオロ−２，３−ジヒドロ−１−ベンゾフラン−２−イル］メチル｝アミン塩酸塩の結晶形態
US20070015138A1 (en) * 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
DK1910346T3 (da) 2005-07-19 2019-05-27 Azevan Pharmaceuticals Inc Beta-lactamyl fenylalanin, cystein og serin vasopressin antagonist
NZ564789A (en) * 2005-07-22 2010-07-30 Myriad Genetics Inc High drug load formulations and dosage forms
EP2377530A3 (fr) 2005-10-21 2012-06-20 Braincells, Inc. Modulation de neurogénèse par inhibition PDE
WO2007053596A1 (fr) 2005-10-31 2007-05-10 Braincells, Inc. Modulation de la neurogenese dont la mediation est assuree par recepteur gaba
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
RU2008135326A (ru) * 2006-03-24 2010-04-27 Вайет (Us) Терапевтические композиции для лечения депрессии
JP4615470B2 (ja) * 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
EP2026813A2 (fr) 2006-05-09 2009-02-25 Braincells, Inc. Neurogenèse induite par le récepteur 5ht
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
EP2046119A2 (fr) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Traitement de troubles psychiatriques
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
KR20090064418A (ko) 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
WO2008034032A2 (fr) * 2006-09-14 2008-03-20 Azevan Pharmaceuticals, Inc. Modulateurs du récepteur cannabinoïde de type bêta-lactame
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080167363A1 (en) * 2006-12-28 2008-07-10 Braincells, Inc Modulation of Neurogenesis By Melatoninergic Agents
WO2008086483A2 (fr) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation de la neurogenèse en utilisant du modafinil
WO2009128058A1 (fr) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Produits psycho-pharmaceutiques
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AU2010310595B2 (en) 2009-10-23 2015-07-16 Janssen Pharmaceutica Nv Disubstituted octahy - dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
WO2011071995A2 (fr) 2009-12-08 2011-06-16 Case Western Reserve University Composés et procédés de traitement de troubles oculaires
US9376424B2 (en) 2010-07-01 2016-06-28 Azevan Pharmaceuticals, Inc. Methods for treating post traumatic stress disorder
JP2014508187A (ja) 2011-03-17 2014-04-03 ルピン・リミテッド 選択的セロトニン再取り込み阻害薬の放出制御医薬組成物
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
WO2014178064A2 (fr) * 2013-04-03 2014-11-06 Zcl Chemicals Limited Procédé amélioré de préparation de maléate de fluvoxamine
HUE053165T2 (hu) 2014-02-07 2021-06-28 Tamogatott Kutatocsoportok Irodaja Szigma-1-receptor-agonista vegyületek új alkalmazása
JP7255967B2 (ja) 2014-03-28 2023-04-11 アゼヴァン ファーマスーティカルズ，インコーポレイテッド 神経変性疾患を治療するための組成物および方法
HUE058759T2 (hu) * 2016-03-10 2022-09-28 Janssen Pharmaceutica Nv Módszerek depresszió kezelésére orexin-2 receptor antagonisták alkalmazásával
CA3044746A1 (fr) 2016-11-24 2018-05-31 Sigmadrugs Kutato Korlatolt Felelossegu Tarsasag Compositions pour la conservation d'organes
BR112020005107A2 (pt) 2017-09-15 2020-11-03 Azevan Pharmaceuticals, Inc. composições e métodos para o tratamento de lesão cerebral

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes

Also Published As

Publication number Publication date
ATA195476A (de) 1977-05-15
FR2304336B1 (fr) 1979-09-28
PL101951B1 (pl) 1979-02-28
AR211153A1 (es) 1977-10-31
GR60052B (en) 1978-04-04
AT340895B (de) 1978-01-10
YU39345B (en) 1984-10-31
BE839744A (fr) 1976-09-20
NL7503310A (nl) 1976-09-22
FI760699A (fr) 1976-09-21
IT1063064B (it) 1985-02-11
DD128332A5 (de) 1977-11-09
DE2610886C2 (fr) 1987-09-24
CH629477A5 (de) 1982-04-30
CA1076142A (fr) 1980-04-22
SU635867A3 (ru) 1978-11-30
DE2610886A1 (de) 1976-10-07
CH626057A5 (fr) 1981-10-30
FI61875C (fi) 1982-10-11
SU620206A3 (ru) 1978-08-15
US4085225A (en) 1978-04-18
ES446192A1 (es) 1977-10-01
ZA761434B (en) 1977-10-26
CH629184A5 (de) 1982-04-15
DK115976A (da) 1976-09-21
SU645559A3 (ru) 1979-01-30
PL100614B1 (pl) 1978-10-31
IL49238A0 (en) 1976-05-31
AU505358B2 (en) 1979-11-15
JPS51125345A (en) 1976-11-01
IE43768B1 (en) 1981-05-20
DK144942B (da) 1982-07-12
SE7603341L (sv) 1976-09-21
GB1535226A (en) 1978-12-13
AU1214776A (en) 1977-09-22
MX9203723A (es) 1992-07-01
PL100052B1 (pl) 1978-08-31
JPS6026776B2 (ja) 1985-06-25
SE410312B (sv) 1979-10-08
AR211011A1 (es) 1977-10-14
HU171030B (hu) 1977-10-28
IE43768L (en) 1976-09-20
DK144942C (da) 1982-12-06
IL49238A (en) 1978-08-31
CH629761A5 (de) 1982-05-14
YU71476A (en) 1982-10-31
FI61875B (fi) 1982-06-30

Similar Documents

Publication Publication Date Title
FR2304336A1 (fr) Composes a effet anti-depressif et procedes de preparation
FR2316201A1 (fr) Similigranite et sa preparation
FR2338251A1 (fr) Nouveau compose peptidique et sa preparation
BE837282A (fr) Polycarbonates thermoplastiques ramifies et leur preparation
MX143009A (es) Cateter mejorado
FR2333519A1 (fr) Catheter uretral
BE857558A (fr) Amelioration des catheters
FR2313685A1 (fr) Hydrophone perfectionne insensible aux accelerations
SE433092B (sv) Forfarande for forvermning och patentering samt streckning av en staltrad
NO143350C (no) 3-oximer av d-17alfa-etynyl-19-nortestosteronestere med befruktningshindrende virkning
BE853418A (fr) Articles a fumer et procede de preparation
SE7606366L (sv) Kateter
FR2345439A1 (fr) Dihydrooxadiazinones et leurs procedes de preparation
AU499080B2 (en) Ortho-aminobutyrophenone derivatives and salts thereof
BE840866A (fr) Composition therapeutique a activite anti-agregante plaquettaire
FR2318863A1 (fr) Bestatine et ses derives
BG27545A3 (en) Method of obtaining of n- tetrahydrofurfuril- noroxymorphones and their salts
FR2301511A1 (fr) Pentafluorsethylarylamines et leurs procedes de preparation
SE7604448L (sv) Diastereoisomerer av fenylaminoetanol-derivat
BE861351A (fr) Composes alcanoylanilides et leur preparation
SE427272B (sv) Framstellning av nikotinamid
FR2319351A1 (fr) Hydantoines et procedes d'obtention
DK122576A (da) Signalspidsverdidetektor
AU510882B2 (en) Esters of naphthyl allohols
FR2304335A1 (fr) Composes a effet anti-depressif

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse
RC Opposition against decision of lapse
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0431, 920616

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0431, 760319

CL Concession to grant licences